Ophthalmic Steroids Drug Market

Ophthalmic Steroids Drugs refer to the steroids drug for the Ophthalmic. A large class of important natural compounds are derived from steroids with a tetracyclic structure. These compounds are called steroids and they are found in all plants and animals. The most abundant steroid in animals is cholesterol C27H46O. The body can synthesize cholesterol, and it can easily absorb cholesterol from food through the intestinal wall. Cholesterol is related to the formation of gallstones, which also harden the arteries. Biochemical changes and degradation of cholesterol produce many steroids that are important in human biochemistry.

Ophthalmic Steroids Drug Market contains market size and forecasts of Ophthalmic Steroids Drug in global, including the following market information:

Global Ophthalmic Steroids Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Ophthalmic Steroids Drug Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Ophthalmic Steroids Drug companies in 2021 (%)

The global Ophthalmic Steroids Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Uveitis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ophthalmic Steroids Drug include Bausch and Lomb, Alimera Sciences, Allergan, Novartis AG, GlaxoSmithKline, Genentech, Pfizer, Bayer AG and Regeneron Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Ophthalmic Steroids Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ophthalmic Steroids Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ophthalmic Steroids Drug Market Segment Percentages, by Type, 2021 (%)

Uveitis

Diabetic Macular Edema

Allergic Conjunctivitis

Keratitis

Others

Global Ophthalmic Steroids Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ophthalmic Steroids Drug Market Segment Percentages, by Application, 2021 (%)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Research Institute

Others

Global Ophthalmic Steroids Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ophthalmic Steroids Drug Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ophthalmic Steroids Drug revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Ophthalmic Steroids Drug revenues share in global market, 2021 (%)

Key companies Ophthalmic Steroids Drug sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Ophthalmic Steroids Drug sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Bausch and Lomb

Alimera Sciences

Allergan

Novartis AG

GlaxoSmithKline

Genentech

Pfizer

Bayer AG

Regeneron Pharmaceuticals

Valeant Pharmaceuticals International